What is vaginal metronidazole used for? Vaginal metronidazole is an antibiotic that is commonly used for an infection called bacterial vaginosis that is caused by certain bacteria. Vaginal ...

Metronidazole 0.75%; vaginal gel; contains parabens. Discontinue if abnormal neurological signs develop. CNS or hepatic disease. Abstain from vaginal intercourse during therapy. Pregnancy (Cat.B).

The drug is available in several forms: immediate-release oral tablets and capsules extended-release oral tablets topical creams, gels, and lotions vaginal gels The different forms of ...

Metronidazole vaginal gel 0.75% to launch immediately -- BRIDGEWATER, N.J., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Solaris Pharma Corporation (“Solaris”) announced today that the U.S. Food and Drug ...

Actavis and Valeant announced that the FDA has approved Metronidazole 1.3% Vaginal Gel for the treatment of bacterial vaginosis. In April 2013, Actavis acquired the rights to Metronidazole 1.3% ...

The generic name of the gel is Metronidazole Vaginal Gel. "Metronidazole vaginal gel is a widely used antibacterial preparation, and its generic version can bring significant savings to the ...

DUBLIN and LAVAL, Quebec — Actavis and Valeant Pharmaceuticals International announced that the Food and Drug Administration approved the new drug application for Metronidazole 1.3% vaginal gel.

Actavis Specialty Brands' acquisition of Valeant's metronidazole vaginal gel is in the 1.3% strength. The deal includes an upfront payment, milestone payments and royalties for the first three ...

The product, a metronidazole vaginal gel to treat bacterial vaginosis, will compete against 3M Co's MetroGel-Vaginal product. 3M has said MetroGel-Vaginal accounted for about 2 percent of its 2005 ...

DUBLIN, July 3, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced its product development partner received final approval from the U.S. Food and Drug Administration for ...

DUBLIN and LAVAL, Quebec, March 25, 2014 /CNW/ - Actavis plc (NYSE: ACT) and Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that the U.S. Food and Drug ...